All Stories

  1. Onychomycosis caused by Syncephalastrum species in a patient with Crohn's Disease in Iraq: A case report
  2. The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis
  3. Pulmonary Aspergillosis Treated With Oral Amphotericin B ( MAT2203 ) in a Patient With HIV ‐Related Cryptococcal Meningitis
  4. Chronic pulmonary aspergillosis in children – a scoping global review
  5. False-Positive IMMY® Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration Buffer
  6. Pulmonary Aspergillosis treated with oral amphotericin B (MAT2203) in a patient with HIV-related Cryptococcal meningitis
  7. Burden of sickle cell anemia in Africa: A systematic review and meta-analysis
  8. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling
  9. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling
  10. Regulatory Gaps in Over-the-Counter Antifungal Access for Vulvovaginal Candidiasis in Uganda: A Policy Analysis Framework
  11. Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis
  12. Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settings
  13. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives
  14. A systematic review of fungi isolated from formalin-preserved human and animal cadavers: A potential health concern to exposed students and technicians
  15. Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings
  16. Vaginal colonization with virulent and methicillin resistant Staphylococcus aureus among Ugandan women in Labour
  17. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives
  18. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling
  19. Re-estimation of the burden of serious fungal diseases in Uganda
  20. Fungal diseases in Africa: Closing the gaps in diagnosis and treatment through implementation research and advocacy
  21. Investigating Metabolic and Molecular Ecological Evolution of Opportunistic Pulmonary Fungal Coinfections: Protocol for a Laboratory-Based Cross-Sectional Study
  22. Prevalence of Histoplasma Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda
  23. Vaginal colonization with virulent Staphylococcus aureus and methicillin resistant Staphylococcus aureus among Ugandan women in labour
  24. Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda
  25. Diagnostic options for pulmonary fungal diseases in Africa
  26. Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda
  27. Improving mycetoma case detection through the training of community health workers in Northern Uganda: protocol for a stepped-wedge cluster-randomized trial
  28. Invasive Fungal Diseases in Africa: A Critical Literature Review
  29. Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
  30. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda
  31. Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda
  32. Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda
  33. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda
  34. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda
  35. Mapping of Chronic Pulmonary Aspergillosis in Africa
  36. Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population
  37. Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
  38. Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases
  39. Evaluation of the Initial 12 Months of a Routine Cryptococcal Antigen Screening Program in Reduction of HIV-Associated Cryptococcal Meningitis in Uganda
  40. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis
  41. Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda
  42. A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility
  43. Fungal asthma among Ugandan adult asthmatics
  44. Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series
  45. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage
  46. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda.
  47. Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting
  48. Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities
  49. Prevalence of Aspergillus fumigatus skin positivity in adults without an apparent/known atopic disease in Uganda
  50. Estimation of the burden of tinea capitis among children in Africa
  51. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis
  52. Deep fungal infections diagnosed by histology in Uganda: A 70-year retrospective study
  53. Treatment of Histoplasmosis
  54. Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting
  55. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage
  56. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist
  57. Intra-cavitary pulmonary cryptococcoma in poorly controlled diabetes mellitus
  58. Skin prick reactivity among asthmatics in East Africa
  59. Erratum to “Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda”
  60. Mycetoma in Uganda: A neglected tropical disease
  61. Deep fungal infections diagnosed by histology in Uganda: a 70-year retrospective study
  62. Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death
  63. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study
  64. Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda
  65. Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device
  66. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients
  67. Getting Histoplasmosis on the Map of International Recommendations for Patients with Advanced HIV Disease
  68. Cor pulmonale complicating chronic pulmonary aspergillosis with fatal consequences: Experience from Uganda
  69. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients
  70. Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
  71. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
  72. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study
  73. Burden of fungal asthma in Africa: A systematic review and meta-analysis
  74. The conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspective
  75. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis
  76. Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
  77. Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid
  78. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis
  79. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients
  80. Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?
  81. Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study: Figure 1.
  82. Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
  83. Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100
  84. Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast